Medication-info.com Search Menu

C-Nate DHA Package Insert

Status:
Prescription (Rx) Facts
Strength:
200 mg, 3 mg, 3 mg, 20 mg, 15 mcg, 1 mg, 400 IU, 100 mg, 30 IU, 1 mg, 20 mg, 28 mg, 30 mg

Prescribing information (package insert) - C-Nate DHA

Description:

Each Softgel Contains:
Omega-3 Fatty Acids (DHA-EPA)200mg
Vitamin B 1 (Thiamine Mononitrate)3 mg
Vitamin B 2 (Riboflavin)3 mg
Vitamin B6 (Pyridoxine HCL)20 mg
Vitamin B 12 (Cyanocobalamin)15 mcg
Folic Acid1 mg
Vitamin D 3 (Cholecalciferol)400 IU
Vitamin C (Ascorbic Acid)100 mg
Vitamin E (d-alpha tocopherol)30 IU
Copper (Cupric Sulfate)1 mg
Zinc (Zinc Oxide)20 mg
Iron (Fumerate)28 mg
Magnesium30 mg

INACTIVE INGREDIENTS: Gelatin, Glycerol, beeswax yellow, lecithin, water-purified and colorant.

INDICATIONS AND USAGE: C-NATE DHA is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.

CONTRAINDICATIONS: C-NATE DHA should not be used by patients with known history of hypersensitivity to any of the listed ingredients.

PRECAUTIONS: Folic Acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B 12 is deficient. Folic Acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.

PEDIATRIC USE: Safety and effectiveness in pediactric patients has not been established.

GERIACTRIC USE: No clinical studies have been performed in patients over 65 to determine whether older persons respond differently from younger persons. Physicians should consider that elderly person may have decreased hepatic, renal, or cardiac function.

DRUG INTERACTIONS: C-NATE DHA softgels are not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine.

ADVERSE REACTIONS: Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.

DOSAGE AND ADMINISTRATION: Usual adult dose: one softgel daily or as prescribed by your doctor.

HOW SUPPLIED: C-NATE DHA is available as a Annato colored softgel, imprinted PRE 01. Available in 30 count bottles with NDC #23359-105-30 and samples with NDC #23359-105-05 and NDC #23359-105-01.

PHYSICIAN SAMPLE NOT FOR RESALE

Recommended Storage: 15°-30°C (59°-86°F) degrees. Protect from light moisture and avoid excessive heat. Dispense original carton.

KEEP OUT OF REACH OF CHILDREN

RX ONLY

CENTURION LABS, LLC

BIRMINGHAM, AL 35243

About this document

Source: FDA drug labeling via NLM DailyMed · View the label on DailyMed

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for C-Nate DHA

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Copper Absorption Inhibitor, Omega-3 Fatty Acid, Vitamin B12, Vitamin B6 Analog, Vitamin C, Vitamin D
Active ingredients Omega-3 fatty acids 200 mg, Thiamine mononitrate 3 mg, Riboflavin 3 mg, Pyridoxine hydrochloride 20 mg, Cyanocobalamin 15 mcg, Folic acid 1 mg, Cholecalciferol 400 IU, Ascorbic acid 100 mg, Alpha-tocopherol, D- 30 IU, Cupric sulfate 1 mg, Zinc oxide 20 mg, Ferrous fumarate 28 mg, Magnesium 30 mg
Dosage form Capsule, gelatin coated
Route Oral
Marketing status not in the current FDA NDC Directory
Company (applicant) Centurion Labs, LLC
FDA approval UNAPPROVED DRUG OTHERUnapproved drug
Manufacturers 1 labelers list this drug on DailyMed
Packages (NDC)
Package
200 mg, 3 mg, 3 mg, 20 mg, 15 mcg, 1 mg, 400 IU, 100 mg, 30 IU, 1 mg, 20 mg, 28 mg, 30 mg – 30 in 1 bottle NDC 23359-105-30
200 mg, 3 mg, 3 mg, 20 mg, 15 mcg, 1 mg, 400 IU, 100 mg, 30 IU, 1 mg, 20 mg, 28 mg, 30 mg – 5 in 1 carton NDC 23359-105-05
200 mg, 3 mg, 3 mg, 20 mg, 15 mcg, 1 mg, 400 IU, 100 mg, 30 IU, 1 mg, 20 mg, 28 mg, 30 mg – 1 in 1 packet NDC 23359-105-01

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.